Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

NCT04865393 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: SPR206

Sponsor

Spero Therapeutics

Collaborators

[object Object]